Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC

T Giaddui,Wenzhou Chen,J. Yu,Liyong Lin,Charles B. Simone,L Yuan,Yutao U. T. Gong,Q. Jackie Wu,Radhe Mohan,Xiaodong Zhang,J. Bluett,Michael Gillin,Kevin L. Moore,Elizabeth O'Meara,Jennifer Presley,Jeffrey D. Bradley,Zhongxing Liao,James M. Galvin,Ying Xiao

Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC

2016

T Giaddui
Wenzhou Chen
J. Yu
Liyong Lin
Charles B. Simone
L Yuan
Yutao U. T. Gong
Q. Jackie Wu
Radhe Mohan
Xiaodong Zhang
J. Bluett
Michael Gillin
Kevin L. Moore
Elizabeth O'Meara
Jennifer Presley
Jeffrey D. Bradley
Zhongxing Liao
James M. Galvin
Ying Xiao

Background To establish the feasibility of the dosimetric compliance criteria of the RTOG 1308 trial through testing against Intensity Modulation Radiation Therapy (IMRT) and Passive Scattering Proton Therapy (PSPT) plans.

Keywords:

Radiology
Randomized controlled trial
Medical physics
Proton therapy
Radiation therapy
Medicine
Chemoradiotherapy
Nuclear medicine
stage ii
engineering tool
planning target volume
overall survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations